tiprankstipranks
Advertisement
Advertisement

IMUX Stock Latest News

Immunic initiated with an Outperform at Wedbush
The FlyImmunic initiated with an Outperform at Wedbush
8d ago
IMUX
Immunic: Buy Rating Reiterated as Analyst Highlights Multiple Sclerosis Milestones and Maintains $22 Price Target
PremiumRatings
Immunic: Buy Rating Reiterated as Analyst Highlights Multiple Sclerosis Milestones and Maintains $22 Price Target
12d ago
IMUX
Sam Slutsky Initiates Buy on Immunic, Citing Late-Stage MS Program, Expansion into Progressive MS, and Strengthened Nurr1-Focused Pipeline
PremiumRatings
Sam Slutsky Initiates Buy on Immunic, Citing Late-Stage MS Program, Expansion into Progressive MS, and Strengthened Nurr1-Focused Pipeline
13d ago
IMUX
Immunic Adds Veteran Finance Leader to Board
PremiumCompany Announcements
Immunic Adds Veteran Finance Leader to Board
14d ago
8K
IMUX
Immunic reports Q2 EPS (80c), consensus ($1.16)
PremiumThe Fly
Immunic reports Q2 EPS (80c), consensus ($1.16)
14d ago
IMUX
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
PremiumTipRanks NewswireQuantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
15d ago
IMUX
QNTM
IMUX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IMUX Upcoming Earnings Report: What to Expect?
21d ago
IMUX
Immunic Updates Corporate Strategy, Highlights Vidofludimus Plans
Premium
Company Announcements
Immunic Updates Corporate Strategy, Highlights Vidofludimus Plans
1M ago
8K
IMUX
Immunic Names CEO Erik Lundgren to Board
PremiumCompany Announcements
Immunic Names CEO Erik Lundgren to Board
2M ago
8K
IMUX
Immunic Expands Equity Plan and Reelects Board Directors
PremiumCompany Announcements
Immunic Expands Equity Plan and Reelects Board Directors
2M ago
8K
IMUX
Immunic Highlights Positive Phase 2 CALLIPER MS Data
PremiumCompany Announcements
Immunic Highlights Positive Phase 2 CALLIPER MS Data
3M ago
8K
IMUX
Immunic Appoints New CEO to Lead MS Strategy
PremiumCompany Announcements
Immunic Appoints New CEO to Lead MS Strategy
3M ago
8K
IMUX
Immunic CEO Daniel Vitt to step down, Erik Lundgren to succeed
PremiumThe FlyImmunic CEO Daniel Vitt to step down, Erik Lundgren to succeed
3M ago
IMUX
B. Riley cuts Immunic target, sees ‘compelling entry point’
Premium
The Fly
B. Riley cuts Immunic target, sees ‘compelling entry point’
3M ago
IMUX
Immunic Appoints Michael Bonney as Board Chair
Premium
Company Announcements
Immunic Appoints Michael Bonney as Board Chair
3M ago
8K
IMUX
Immunic appoints Michael Bonney as chair
PremiumThe Fly
Immunic appoints Michael Bonney as chair
3M ago
BIIB
IMUX
Immunic price target lowered to $19 from $26 at Roth Capital
PremiumThe Fly
Immunic price target lowered to $19 from $26 at Roth Capital
3M ago
IMUX
Immunic reports Q1 EPS ($1.08), consensus (96c)
PremiumThe Fly
Immunic reports Q1 EPS ($1.08), consensus (96c)
3M ago
IMUX
IMUX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
IMUX Upcoming Earnings Report: What to Expect?
4M ago
IMUX
Immunic initiated with an Outperform at LifeSci Capital
PremiumThe FlyImmunic initiated with an Outperform at LifeSci Capital
4M ago
IMUX
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 4/30/26?
Premium
Market News
Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 4/30/26?
4M ago
IMA
VTI
Immunic price target adjusted to $22 from $5 at H.C. Wainwright
Premium
The Fly
Immunic price target adjusted to $22 from $5 at H.C. Wainwright
4M ago
IMUX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >